BACKGROUND: The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has been associated with decreased risk of diabetes and obesity, both disorders linked to cognitive impairment. We tested whether this polymorphism is associated with cognition. METHODS: Two thousand nine hundred sixty-one participants (mean age, 74.1; 41% Black; 52% women) were administered the Modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST) at baseline and 4 year follow-up. Test scores were adjusted for age, sex, education, cerebrovascular disease, depression and APOE genotype and additionally for race. We determined the association between Ala allele and development of cognitive decline (3MS decline of > or = 5 points). RESULTS: At baseline, unadjusted scores on both cognitive tests were higher for Ala carriers compared to non-carriers (3MS, 94.2 versus 92.5, p<0.001; DSST, 40.2 versus 34.5, p<0.001). Similarly, follow-up scores were higher for Ala carriers. Multivariable adjustment led to similar results; additional adjustment for race attenuated the baseline 3MS results. After 4 years, 17.5% of Ala carriers developed cognitive decline compared to 25% among non-carriers (unadjusted OR=0.61; 95%CI, 0.46-0.82; adjusted OR=0.75; 95%CI, 0.55-1.02). Further adjustment for metabolic variables including fasting blood glucose and lipid level did not change the results. CONCLUSIONS: The PPAR-gamma Ala12 allele carriers may have less risk of developing cognitive decline.
BACKGROUND: The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has been associated with decreased risk of diabetes and obesity, both disorders linked to cognitive impairment. We tested whether this polymorphism is associated with cognition. METHODS: Two thousand nine hundred sixty-one participants (mean age, 74.1; 41% Black; 52% women) were administered the Modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST) at baseline and 4 year follow-up. Test scores were adjusted for age, sex, education, cerebrovascular disease, depression and APOE genotype and additionally for race. We determined the association between Ala allele and development of cognitive decline (3MS decline of > or = 5 points). RESULTS: At baseline, unadjusted scores on both cognitive tests were higher for Ala carriers compared to non-carriers (3MS, 94.2 versus 92.5, p<0.001; DSST, 40.2 versus 34.5, p<0.001). Similarly, follow-up scores were higher for Ala carriers. Multivariable adjustment led to similar results; additional adjustment for race attenuated the baseline 3MS results. After 4 years, 17.5% of Ala carriers developed cognitive decline compared to 25% among non-carriers (unadjusted OR=0.61; 95%CI, 0.46-0.82; adjusted OR=0.75; 95%CI, 0.55-1.02). Further adjustment for metabolic variables including fasting blood glucose and lipid level did not change the results. CONCLUSIONS: The PPAR-gamma Ala12 allele carriers may have less risk of developing cognitive decline.
Authors: W H Linda Kao; Josef Coresh; Alan R Shuldiner; Eric Boerwinkle; Molly S Bray; Frederick L Brancati Journal: Diabetes Date: 2003-06 Impact factor: 9.461
Authors: Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Mohammad Salehi-Sadaghiani; Mehrak Javadi-Paydar; Mohammad Hadi Gharedaghi; Ali Zandieh; Pouria Heydarpour; Yashar Yousefzadeh-Fard; Ahmad Reza Dehpour Journal: Psychopharmacology (Berl) Date: 2012-05-01 Impact factor: 4.530
Authors: Nancy A West; Jonathan V Tingle; Jeannette Simino; Elizabeth Selvin; Jan Bressler; Thomas H Mosley Journal: Alzheimer Dis Assoc Disord Date: 2018 Apr-Jun Impact factor: 2.703
Authors: Robert Stewart; Robert J Weyant; Melissa E Garcia; Tamara Harris; Lenore J Launer; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe; Anne B Newman Journal: J Am Geriatr Soc Date: 2013-02 Impact factor: 5.562
Authors: Ramon Casanova; Santiago Saldana; Michael W Lutz; Brenda L Plassman; Maragatha Kuchibhatla; Kathleen M Hayden Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-03-09 Impact factor: 4.077